Ummul. Asfeen. DO, MBBS
@asfeen_ummul
Followers
347
Following
1K
Media
19
Statuses
340
@MDAndersonnews Fellow Palliative Care •@GACancerCenter • mission #EndCancer • Vice President #ASCO IMG CoP • #ASCOReviewer • @HemOncFellows
Houston, Texas
Joined April 2017
#ASCO
#ASCOconnect
#MedTwitter Thanks @ASCO for highlighting this publication 🙏 Dr. @Charbel_matar1 & I shared important tips to help navigate the fellowship interview process. Good luck!! 🍀 @MDAndersonNews
@GACancercenter
#ASCOPallOnc
@HemOncFellows
Drs. @Charbel_matar1 and @asfeen_ummul share essential tips for confidently navigating the fellowship interview process and securing a successful match. https://t.co/ucF8z45O9T
#MedTwitter #OncTwitter
0
3
13
Dr. @KalantriShreyas highlights practical guidance on navigating contract negotiations for early-career oncologists, shared by panelists during an #ASCO25 Trainee and Early Career Lounge session. Read more: https://t.co/iyDwUCdkiP
#ASCOConnection
2
3
7
Thank you @ASCO for sharing this piece. Appreciated the opportunity to share the insights of @MEmmichDO, @cardismith, @JTrentMDPhD, and Dr. Akeem Lewis. Each offered invaluable advice for early-career oncologists navigating their first contracts. #ASCO25 #ASCOConnection
Dr. @KalantriShreyas highlights practical guidance on navigating contract negotiations for early-career oncologists, shared by panelists during an #ASCO25 Trainee and Early Career Lounge session. Read more: https://t.co/iyDwUCdkiP
#ASCOConnection
1
4
13
💥 Exciting findings from MD Anderson Cancer Center! mRNA vaccines may do more than prevent infections — they could also enhance cancer immunotherapy. A new study found that patients with NSCLC and metastatic melanoma who received a SARS-CoV-2 mRNA vaccine within 100 days of
0
2
5
November 7th is the date! Join us for both of these events during lung cancer awareness month. We are stronger and united in this mission to end lung cancer in Mississippi. #lcsm @PierredeDelva1 @KelseyKochMD
@rodrocconi @UMMC_Cancer @AmericanCancer Cc: @EGFRResisters
0
4
14
This was a great meeting. Such awesome work being done. @realbowtiedoc @RyanNipp @crisbergerot
#PalloncCoP #SuppOnc #ASCOQLTY25 #ASCO #EndCancer
@RyanNipp @PallOncCoP @MazieTsangMD @DarcyBurbage @Chaosdyna @crisbergerot @GretchenMcnally @BbaharK @asfeen_ummul @veladconmigo @FionnualaCrowle @jillfeldman4 @IshwariaMD @BenWThompson @bosnjaksupport Love discussions with both @RyanNipp and @crisbergerot regarding practice changing influence including negative #trials of #fintox interventions as well as #FederalFunding of trials in the US @PallOncCoP
@IshwariaMD
@CThompson_MD
@MazieTsangMD
@DarcyBurbage
@Chaosdyna
0
1
7
✨ Clarity is sometimes mistaken for destiny. Honored to share my reflection on purpose, growth, and the paths that find us. @ASCO #BCAM🎀 #connection
https://t.co/6LyF9zzXhz
1
1
1
‼️🚨 Tonight! Tune in for this great space! ⬇️⬇️⬇️
✍️Mark your calendar for our upcoming space❗️ Fellowship Rank Order List: Insights and Practical Tips‼️ 🌟Speaker: @Taha_CancerDoc, Fellowship APD at University of Oklahoma 🌟Host: @DrSAHaddad, Fellow at UT Health San Antonio 🗓️Wednesday, October 15, 2025 📍X space, 6 pm EST
0
2
9
Check it out! 🛑Survey results from patients and caregivers with #lcsm on what would make it easier for them to participate in high quality clinical trials. Having a navigator they trust and flexibility in scheduling and ease stood out as priority (90%) @ipreeshagul
4
5
22
Excited to share our work at #ASCOQLTY25! 🩺🎗️ 📍Poster Session B 🗓️ Oct 11, 2025 | ⏰ 7:00–7:55 AM & 12:15–1:30 PM ET 🧾 Abstract: Determinants of Patient-Reported Outcomes Among Hospitalized Cancer Patients Sorry to miss attending in person due to clinical duties, but grateful
1
7
34
Good Morning ATX. Great to be back and fantastic to see this reminder @AustinAirport that the #1 cancer center in the world is coming to town to #endcancer in central Texas and beyond!
0
0
0
#Priorauthorization #UtilizationManagement for costly 2nd-line 💊 is understandable but nearly one-half of plans have quantity limits for generic ondansetron, a cheap ($16 for 60 8mg tabs) & effective 1st-line drug Make this make sense. #fixPriorAuth
https://t.co/9rSJtTDYGv
4
13
34
2
5
38
Excited to share our article, “First Job Search Tips for Hematology-Oncology Fellows,” now featured on #ASCOconnection! @ASCO @ASCOTECAG @HemOncFellows @IMG_Oncologists @ASridharMD Check it out here 👉
0
0
1
Grateful to welcome @RepSherriBiggs’ team to our Comprehensive Cancer Center 🌿 Through #ASCOAdvocacy we’re tackling barriers to bring cancer care closer to home for SC-3’s rural families & veterans.” #RuralOncology
#Ruralhealth #CancerCareCloseToHome #SelfRegionalHealthcare
0
0
3
Thrilled to host fellow @PallOncCoP champ @crisbergerot and @montypal as they present their recently published @OncJournal article alongside @jatwanikaran. Mark your calendar! 📅 @OncoAlert🚨 #OncoAlertAF
@FadiHaddad_MD
@Abdallah81MD
@Erman_Akkus
@bavilima
@acampsmalea
🧠 Can mindfulness support patients with metastatic renal cell carcinoma? Join The Oncologist’s eJournal Club on Thursday, October 30 from 6–7pm EDT for a live social media discussion, hosted by @realbowtiedoc. Joining instructions: https://t.co/oyy1UwLPH2
0
10
23
The Call for Abstracts closes on October 30! Begin your submission now and finish it later. We’re accepting abstracts from investigators across the oncology community for consideration for the NCCN 2025 Annual Conference General Poster Session. Submit now: https://t.co/8u2s8STlJj
0
1
2
In this short video, Dr. @jrgralow shares why finding the best dose of drug for each patient is important. Watch now and learn how you can get involved: https://t.co/WIcdFjZ4CU
0
0
0
Honored to have our poster selected for an awarded presentation at #TXSCO2025 in Houston! Grateful to share the work from my Hereditary Cancer Fellowship at @GACancerCenter
@AUG_University Dr. JWHenson #AwardedPoster #UniversalGeneticTesting #OncoDaily #MDAndersonnews #TXSCOnews
3
1
8
Thrilled to have presented at the Texas Society of Clinical Oncology Annual Conference in Houston @TxSCOnews @GACancerCenter
@MDAndersonNews @ASCO
0
0
2